Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
- 12 September 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in International Journal of Neuroscience
- Vol. 124 (5), 307-321
- https://doi.org/10.3109/00207454.2013.833510
Abstract
Compelling evidence from basic molecular biology has demonstrated the dual roles of microglia in the pathogenesis of Alzheimer's disease (AD). On one hand, microglia are involved in AD pathogenesis by releasing inflammatory mediators such as inflammatory cytokines, complement components, chemokines, and free radicals that are all known to contribute to beta-amyloid (Aβ) production and accumulation. On the other hand, microglia are also known to play a beneficial role in generating anti-Aβ antibodies and stimulating clearance of amyloid plaques. Aβ itself, an inducer of microglia activation and neuroinflammation, has been considered as an underlying and unifying factor in the development of AD. A vicious cycle of inflammation has been formed between Aβ accumulation, activated microglia, and microglial inflammatory mediators, which enhance Aβ deposition and neuroinflammation. Thus, inhibiting the vicious cycle seems to be a promising treatment to restrain further development of AD. With increasing research efforts on microglia in AD, intervention of microglia activation and neuroinflammation in AD may provide a potential target for AD therapy in spite of the provisional failure of nonsteroidal antiinflammatory drugs in clinical trials.Keywords
This publication has 102 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology & Medicine, 2013
- Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A2 activation in astrocytes and cerebral endothelial cellsNeuroscience, 2011
- Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulationGlia, 2010
- Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s diseaseBrain, Behavior, and Immunity, 2009
- Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1β levels and leakage of the blood-brain barrierMatrix Biology, 2009
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathologica, 2009
- Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's DiseaseNeuron, 2008
- Glia maturation factor modulates β-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damageBrain Research, 2008
- The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survivalClinical Neuroscience Research, 2006
- PKCε increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2006